Pre-Exposure Prophylaxis with Vasculotide Enhances Survival and Alleviates Hematopoietic and Gastrointestinal Injury Following Lethal Total Body Irradiation
International Journal of Molecular Sciences · 19.02.2026 · 27 (4) · 2001
DOI: 10.3390/ijms27042001 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 19.02.2026. Verfasst von Li Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Armed Forces Radiobiology Research Institute, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA. Hauptthemen laut MEDLINE: Whole-Body Irradiation, Acute Radiation Syndrome, Gastrointestinal Tract, Radiation-Protective Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: AFRRI intramural grant, NIH/NIAID/AFRRI Interagency Agreement.
Abstract (Originalsprache)
No US Food and Drug Administration (FDA)-approved prophylaxis is currently available for Acute Radiation Syndrome (ARS), which remains a significant threat to military and civilian populations. In this study, we investigated Vasculotide (VT), a Tie2 receptor agonist mimic, as a novel pre-exposure prophylaxis designed to stabilize the vascular endothelium, one of primary targets of radiation-induced damage. To evaluate its efficacy, female B6D2F1/J mice were exposed to 9.5 Gy total body irradiation (TBI), with VT administered subcutaneously at 12 and 2 h prior to exposure. Assessments included 30-day survival, biomarkers of vascular injury, proinflammatory cytokine/chemokine profiling, and evaluation of hematopoietic (H) and gastrointestinal (GI) recovery. Our findings demonstrate that VT significantly increased 30-day survival in a dose-dependent manner, achieving a 30% survival advantage at the 20 μg/kg dose. Furthermore, VT provided robust protection against radiation-induced vascular activation and injury, effectively alleviating damage to the bone marrow (BM) and GI tract. Taken together, these results identify VT as a promising prophylactic countermeasure for ARS. By targeting the Tie2 pathway to preserve vascular integrity, VT addresses a critical gap in medical countermeasures, offering a viable strategy to enhance survival and accelerate multi-organ recovery in radiological mass-casualty scenarios.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Armed Forces Radiobiology Research Institute, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA.
- Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, MD 20817, USA.
- Department of Pathology, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA.
- Comparative Pathology, Department of Laboratory Animal Resources, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA.
- Department of Pharmacology and Molecular Therapeutics, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA.
- Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA.
ORCID-Profile: Li Wang, Wanchang Cui, Juliann G Kiang
Förderung
- AFRRI intramural grant
- NIH/NIAID/AFRRI Interagency Agreement
Zitieren
APA
Wang, L., Lin, B., Zhai, M., Hull, L., Rothstein, A., Cleveland, K. S., Ellery, H., Cui, W., Xiao, M., & Kiang, J. G. (2026). Pre-Exposure Prophylaxis with Vasculotide Enhances Survival and Alleviates Hematopoietic and Gastrointestinal Injury Following Lethal Total Body Irradiation. International Journal of Molecular Sciences, 27(4), 2001. https://doi.org/10.3390/ijms27042001
Vancouver
Wang L, Lin B, Zhai M, Hull L, Rothstein A, Cleveland KS, et al. Pre-Exposure Prophylaxis with Vasculotide Enhances Survival and Alleviates Hematopoietic and Gastrointestinal Injury Following Lethal Total Body Irradiation. International Journal of Molecular Sciences. 2026;27(4):2001. doi:10.3390/ijms27042001
BibTeX
@article{Wang2026,
author = {Wang, Li and Lin, Bin and Zhai, Min and Hull, Lisa and Rothstein, Asher and Cleveland, Katherine S and Ellery, Hengying and Cui, Wanchang and Xiao, Mang and Kiang, Juliann G},
title = {Pre-Exposure Prophylaxis with Vasculotide Enhances Survival and Alleviates Hematopoietic and Gastrointestinal Injury Following Lethal Total Body Irradiation},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {4},
pages = {2001},
doi = {10.3390/ijms27042001}
}
EUVIMED